https://biotechmorning.com/news/astellas-xlmtm-gene-therapy-second-chance Biotech Morning en 2026-05-11T14:11:06.268Z The Gene Therapy That Killed Four Kids Is Getting a Second Chance https://biotechmorning.com/news/fda-commissioner-makary-ouster-biotech-impact Biotech Morning en 2026-05-11T14:10:22.903Z The FDA Just Lost Its Boss (Again). Here's Why Biotech Is Celebrating. https://biotechmorning.com/news/cellcentric-220m-series-d-oral-myeloma-drug Biotech Morning en 2026-05-11T14:09:33.153Z The Pill That Could Rescue Myeloma Patients After Everything Else Fails https://biotechmorning.com/news/amgen-quantinuum-quantum-computing-ipo Biotech Morning en 2026-05-11T14:08:45.472Z Amgen Just Bet on a Computer That Doesn't Fully Exist Yet https://biotechmorning.com/news/vyvgart-first-treatment-all-myasthenia-gravis-serotypes Biotech Morning en 2026-05-11T14:07:58.292Z The Drug That Just Became the First Treatment for Every Type of This Rare Disease https://biotechmorning.com/news/banyan-bioinnovations-100m-launch-icon-partnership Biotech Morning en 2026-05-10T14:06:13.214Z The $100M Biotech That Wants to Build Companies Like IKEA Builds Furniture